| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44.3B | $42.0B | $40.1B | $43.7B | $43.1B | $34.6B | $8.3B | $7.8B |
| Cost of Revenue | $19.3B | $18.7B | $18.0B | $19.1B | $18.5B | $15.0B | $13.2B | $12.7B |
| Gross Profit | — | — | — | — | — | — | $4.4B | $4.1B |
| R&D Expense | $2.9B | $2.8B | $2.7B | $2.9B | $2.7B | $2.4B | $2.4B | — |
| SG&A Expense | $12.3B | $11.7B | $10.9B | $11.2B | $11.3B | $9.7B | $9.8B | $9.7B |
| Operating Income | $8.1B | $6.8B | $6.5B | $8.4B | $8.4B | $5.4B | $4.5B | $3.6B |
| Net Income | $6.5B | $13.4B | $5.7B | $6.9B | $7.1B | $4.5B | $1.0B | $0.7B |
| EPS (Basic) | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 | $2.52 | $0.59 | $0.37 |
| EPS (Diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $0.59 | $0.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $86.7B | $81.4B | $73.2B | $74.4B | $75.2B | $72.5B | $67.9B | $67.2B |
| Current Assets | $26.0B | $23.7B | $22.7B | $25.2B | $24.2B | $20.4B | $15.7B | $14.6B |
| Cash & Equivalents | $8.5B | $7.6B | $6.9B | $9.9B | $9.8B | $6.8B | $3.9B | $3.8B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $16.5B | $14.2B | $13.8B | $15.5B | $13.1B | $11.9B | $10.9B | $9.0B |
| Stockholders' Equity | $52.1B | $47.7B | $38.6B | $36.7B | $35.8B | $32.8B | $31.1B | $30.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.6B | $8.6B | $7.3B | $9.6B | $10.5B | $7.9B | $6.1B | $6.3B |
| Investing Cash Flow | $-2.4B | $-2.3B | $-3.1B | $-1.7B | $-2.0B | $-2.2B | $-1.8B | $-1.4B |
| Capital Expenditures | $2.2B | $2.2B | $2.2B | $1.8B | $1.9B | $2.2B | $1.6B | $1.4B |
| Financing Cash Flow | $-6.3B | $-5.4B | $-7.1B | $-7.6B | $-5.5B | $-2.8B | $-4.3B | $-10.4B |